EN
登录

前Truveris首席执行官AJ Loiacono的Judi Health以2.52亿美元融资达到32.5亿美元估值,致力于解决药品定价混乱问题

Former Truveris CEO AJ Loiacono's Judi Health Hits $3.25B Valuation With $252M Raise To Fix Drug Pricing Chaos

benzinga 等信源发布 2025-09-27 15:01

可切换为仅中文


AJ Loiacono

AJ Loiacono

's

‘s

healthcare

医疗保健

software startup

软件初创公司

Judi Health

朱迪健康

reduced costs by 11% for 1,800 plan members and cut claims processing times from more than six months to 18 days. The 53-year-old entrepreneur founded the company, formerly known as

为1800名计划成员减少了11%的成本,并将索赔处理时间从六个月以上缩短到18天。这位53岁的企业家创立了这家公司,之前名为

Capital Rx

资本处方药公司

, to address inefficiencies in an industry where administrative spending reaches $1 trillion annually,

,以解决一个行政开支每年高达1万亿美元的行业的低效问题,

Forbes

福布斯

reported.

已报告。

Judi Health on Tuesday

周二的朱迪健康

announced

宣布

a $400 investment, including a $252 million Series F funding round led by Wellington Management and General Catalyst that doubled the company’s valuation to $3.25 billion. The funding round is set to close in October.

一笔400美元的投资,其中包括由Wellington Management和General Catalyst领投的2.52亿美元F轮融资,使公司估值翻倍至32.5亿美元。本轮融资预计将在10月结束。

Notable investors include Goldman Sachs Asset Management and Generation Investment Management, chaired by former Vice President

知名投资者包括高盛资产管理公司和由前副总统主持的世代投资管理公司

Al Gore

阿尔·戈尔

, Forbes reported.

,福布斯报道。

Don't Miss:

不要错过:

Power Outages Up 20% a Year —

每年停电次数增加20% —

Here's the U.S. Company Helping Americans Go Off-Grid Safely

以下是帮助美国人安全脱离电网的美国公司

If there was a new fund backed by Jeff Bezos offering a

如果有杰夫·贝索斯支持的新基金提供一个

7-9% target yield with monthly dividends would you invest in it

7-9% 的目标收益率,每月分红,你会投资吗?

?

From Pharmacy Consulting to $3.7 Billion Revenue Healthcare Platform

从药房咨询到37亿美元收入的医疗保健平台

Loiacono previously co-founded pharmacy benefits consulting firm

洛亚科诺之前共同创立了药房福利咨询公司

Truveris

特鲁维里斯

, where he spent eight years as a top executive and CEO, witnessing American drug pricing’s deep dysfunction firsthand, Forbes reported. He launched Capital Rx with colleagues

据《福布斯》报道,他在那里作为高管和首席执行官工作了八年,亲眼目睹了美国药品定价的严重功能障碍。随后他与同事一起创办了 Capital Rx。

Ryan Kelly

瑞安·凯利

, now Judi Health’s chief technology officer, and

,现在是Judi Health的首席技术官,和

Joseph Alexander

约瑟夫·亚历山大

in 2017.

2017年。

The company developed Judi, a modular cloud-based software that cuts through pricing opacity with transparency. Rather than playing pricing games, Capital Rx charges flat administrative fees on either a per-member monthly basis or per-claim structure, according to the outlet.

该公司开发了 Judi,这是一款模块化的基于云的软件,可以通过透明度消除价格不透明。据该媒体报道,Capital Rx 不玩定价游戏,而是收取固定的管理费用,按照每位成员每月或每笔索赔的结构收取。

Drug prices

药品价格

get set using the publicly available national average drug acquisition cost database maintained by federal centers for Medicare and Medicaid services.

通过联邦医疗保险和医疗补助服务中心维护的公开可用的全国平均药物获取成本数据库来获取和设置。

This approach helped build a substantial pharmacy benefit management business expecting $3.7 billion in revenue this year, up over 75% from last year’s $2.1 billion, Forbes reported. The technology handles the administrative work of claims, but the company does not take on the risk of paying for them..

这种做法帮助建立了一个庞大的药品福利管理业务,预计今年将获得37亿美元的收入,比去年的21亿美元增长了75%以上。该技术处理理赔的管理工作,但公司不承担支付理赔的风险。

Trending: Backed by $300M+ in Assets and Microsoft's Climate Fund,

趋势:拥有超过 3 亿美元的资产和微软气候基金的支持,

Farmland LP

农田有限合伙公司

Opens Vital Farmland III to Accredited Investors

向合格投资者开放重要农田III

Healthcare’s $5 Trillion Crisis Meets Silicon Valley Innovation

医疗保健的5万亿美元危机遭遇硅谷创新

U.S. pharmacy spending increased by $50 billion in 2024 to $487 billion at net manufacturer prices, driven by growth in oncology, immunology, cardiovascular, obesity, and diabetes drugs, with GLP-1 therapies such as Ozempic and Wegovy cited by

2024年,美国药房支出按生产商净价计算增加了500亿美元,达到4870亿美元,主要受肿瘤学、免疫学、心血管、肥胖症和糖尿病药物的推动,其中特别提到了GLP-1类疗法,如Ozempic和Wegovy。

PwC

普华永道

as key inflators.

作为主要的通胀驱动因素。

“The mission of our company is to give our country the infrastructure we need to get the healthcare we deserve,” Loiacono told Forbes. “Until we get control over that infrastructure and modernize it, we can’t begin to advance care in this country.”

“我们公司的使命是为我们的国家提供所需的基础设施,以获得我们应得的医疗保健,”洛亚科诺告诉福布斯。“在我们掌控该基础设施并使其现代化之前,我们无法开始提升这个国家的医疗保健水平。”

The dysfunction runs deeper than most realize, according to the outlet. Medical benefits and prescription coverage operate through completely separate channels, creating duplication, higher costs, and massive frustration for doctors and patients. Drug pricing represents a particular maze of rebates, clawbacks, and fees layered upon fees..

据该媒体称,这一功能障碍比大多数人意识到的要深。医疗福利和处方药覆盖范围通过完全独立的渠道运作,造成重复、更高的成本,以及医生和患者的极大挫败感。药品定价则代表着一个特别复杂的迷宫,包含回扣、追回款项和层层叠加的费用。

PwC projects the 2026 medical cost trend at 8.5% for the group market and 7.5% for the individual market, and restates 2024 and 2025 trends higher than previously projected.

普华永道预测,2026年团体市场的医疗成本趋势为8.5%,个人市场为7.5%,并重申2024年和2025年的趋势高于此前的预测。

See Also: Shaquille O'Neal Wants People to Take Heart Health Seriously —

另请参阅:沙奎尔·奥尼尔希望人们认真对待心脏健康 ——

This AI-ECG Could Make That Easier

这种人工智能心电图可以让诊断更容易。

Wall Street Bets Big On $20 Billion Healthcare Infrastructure Play

华尔街豪赌200亿美元的医疗基础设施项目

The real prize lies in medical benefits, a far larger market than pharmacy coverage, according to Forbes. Combining medical and pharmacy claims represents healthcare’s holy grail, eliminating industry duplication and administrative waste.

福布斯指出,真正的奖励在于医疗福利,这是一个比药房覆盖更大的市场。合并医疗和药房索赔代表了医疗保健的圣杯,消除了行业的重复和行政浪费。

“They are building what we believe is the first unified claims system, which is a huge shift in how benefits are administered,”

“他们正在构建我们认为是第一个统一的索赔系统,这是福利管理方式的巨大转变,”

General Catalyst

通用催化剂

Managing Director

总经理

Holly Maloney

霍莉·马洛尼

said. “We think there’s absolutely a $20 billion business to be built here.”

说:“我们认为这里绝对有一个价值200亿美元的生意可做。”

Judi Health

朱迪健康

has already signed major employer plans and a third-party administrator licensing its technology, representing 40,000 lives for the new health administration product, Forbes reported.

据《福布斯》报道,已经与主要雇主计划和第三方管理员签署了协议,授权其技术,代表了新健康管理产品覆盖的40,000人。

Judi Health on Wednesday

周三的朱迪健康状况

announced

宣布

a multiyear partnership with the Charlotte Hornets, becoming the NBA team's exclusive jersey patch sponsor ahead of its Oct. 22 home opener against the Brooklyn Nets.

与夏洛特黄蜂队建立多年合作伙伴关系,成为该NBA球队独家球衣广告赞助商,其主场揭幕战将于10月22日对阵布鲁克林篮网队。

Read Next: 7 Million Gamers Already Trust Gameflip With Their Digital Assets —

接下来阅读:700万玩家已经信任Gameflip处理他们的数字资产——

Now You Can Own a Stake in the Platform

现在你可以拥有该平台的一部分股份了。

Image: Shutterstock

图片:Shutterstock

Market News and Data brought to you by Benzinga APIs

由Benzinga API提供的市场新闻和数据

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

© 2025 Benzinga.com. Benzinga 不提供投资建议。保留所有权利。